Holen Sie sich die Stockscreener-App
4.20
3.45%
0.14
Handel nachbörslich:
4.10
-0.10
-2.38%
Grace Therapeutics Inc Aktie (GRCE) Neueste Nachrichten
Market Trends: Is KIMPRN a play on infrastructure spending2026 WrapUp & Fast Entry High Yield Tips - baoquankhu1.vn
Traumatic Brain Injury Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Lab - Barchart.com
Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update - MarketBeat
Is Grace Therapeutics Inc. stock positioned for digital transformation2025 Trade Ideas & AI Forecasted Entry and Exit Points - Naître et grandir
Aug Selloffs: What is the cash position of Willis Lease Finance Corporation2025 Short Interest & Technical Confirmation Alerts - baoquankhu1.vn
Aug Patterns: Will Haoxin Holdings Limited stock outperform Nasdaq indexTrend Reversal & Weekly Watchlist for Hot Stocks - Naître et grandir
Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica
Aug Momentum: Is now the right time to enter SAIA2025 AllTime Highs & Low Risk High Win Rate Picks - baoquankhu1.vn
GRCE SEC FilingsGrace Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
GRCE: IV nimodipine shows superior efficacy and compliance over oral forms for aSAH treatment - TradingView
Institution Moves: What is Grace Therapeutics Incs valuation compared to sector2025 Trade Ideas & Safe Entry Zone Tips - baoquankhu1.vn
Is OXLC.G forming a breakout patternPortfolio Performance Report & Free Daily Entry Point Trade Alerts - mfd.ru
Rate Hike: Can Grace Therapeutics Inc weather a recessionProfit Target & Reliable Price Action Trade Plans - baoquankhu1.vn
ANTX PE Ratio & Valuation, Is ANTX Overvalued - Intellectia AI
PYPD PE Ratio & Valuation, Is PYPD Overvalued - Intellectia AI
GRCE Should I Buy - Intellectia AI
Buy Signal: Is MSAI forming a breakout pattern2025 Trading Volume Trends & Expert Approved Momentum Ideas - baoquankhu1.vn
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - Bitget
Grace CEO joins TD Cowen event with IV nimodipine program - Stock Titan
The 9 Best Robinhood Penny Stocks in March 2026 - The Stock Dork
Stop Loss: Does CRVS stock benefit from AI growthWeekly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
NVIDIA Corporation (NVDA) to Supply Standalone Grace CPUs in Landmark Data Center Rollout - Yahoo Finance
Companies Like Grace Therapeutics (NASDAQ:GRCE) Are In A Position To Invest In Growth - Sahm
ADAR1 discloses 9.9% Grace Therapeutics (GRCE) ownership in 13G/A - Stock Titan
Aug PreEarnings: Is Grace Therapeutics Inc a turnaround storyMarket Risk Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
SAPMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can MetaVia Inc. stock outperform in a bear marketTreasury Yields & Proven Capital Preservation Methods - mfd.ru
Will Grace Therapeutics Inc. stock sustain high P E ratios2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
Does Grace Therapeutics Inc. have a sustainable dividend2025 Volume Leaders & Real-Time Volume Surge Alerts - mfd.ru
Is EVGOW stock a top momentum playPortfolio Update Report & Daily Entry Point Alerts - mfd.ru
Is SFYX stock good for wealth creation2025 Price Momentum & Real-Time Volume Analysis - mfd.ru
GRCE PE Ratio & Valuation, Is GRCE Overvalued - Intellectia AI
BOL.ST Should I Buy - Intellectia AI
Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO) - The Globe and Mail
Is Grace Therapeutics Inc. still a buy after recent gainsWeekly Trading Summary & Technical Pattern Alert System - mfd.ru
Amy C. Moore and Roland Matthews: When Professional Excellence Meets Personal Grace - Oncodaily
Grace Therapeutics announces third quarter 2026 financial results, provides business update - marketscreener.com
Grace Therapeutics (NASDAQ:GRCE) Announces Earnings Results - MarketBeat
Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi - GuruFocus
Is Grace Therapeutics Inc. a cyclical or defensive stockWeekly Stock Summary & Accurate Trade Setup Notifications - mfd.ru
Grace: Fiscal Third Quarter Earnings Overview - Bitget
Grace: Fiscal Q3 Earnings Snapshot - kare11.com
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - The Manila Times
Grace Therapeutics Q3 2026 Financial Results and Business Update - TradingView
April 23 FDA target date set for Grace’s GTx-104 aSAH drug - Stock Titan
Grace Therapeutics, Inc. SEC 10-Q Report - TradingView
Why is Grace Therapeutics Inc. stock going upShort Setup & Verified Trade Idea Suggestions - mfd.ru
Jobs Data: Can Grace Therapeutics Inc weather a recession2025 Sector Review & Expert-Curated Trade Recommendations - baoquankhu1.vn
Aug Selloffs: What are the risks of holding BioXcel Therapeutics Inc.Weekly Volume Report & Consistent Growth Stock Picks - mfd.ru
Grace Therapeutics (GRCE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Volatility Watch: Can SolarBank Corporation generate free cash flowJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Aug Fed Impact: Why is Grace Therapeutics Inc stock going upMarket Trend Review & Smart Allocation Stock Tips - baoquankhu1.vn
Quarterly Recap: Does IMMR stock benefit from AI growthMarket Growth Review & Fast Momentum Entry Tips - baoquankhu1.vn
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):